A STUDY ON EPIPHEGUS VIRGINIANA 30C TO REDUCE DISABILITY CAUSED BY MIGRAINE

A CLINICAL STUDY TO ASSESS THE EFFICACY OF EPIPHEGUS VIRGINIANA 30C IN REDUCING MIGRAINE - RELATED DISABILITY USING THE MIDAS SCALE - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/11/098000

Enrollment

Registered

2025-11-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G437- Chronic migraine without aura Health Condition 2: G431- Migraine with aura Health Condition 3: G430- Migraine without aura

Interventions

Intervention1: Epiphegus Virginiana 30C Homeopathic Remedy: The intervention involves the administration of Epiphegus Virginiana 30C, a homoeopathic remedy, to individuals suffering from migraine-rela

one dose at interval of 7 days for the period of 3 months to 6 months as per requirement of the case. The treatment aims to reduce the frequency, intensity, and disability associated with migraines, a

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age groups between 18-60 years. Pre-diagnosed cases of migraine with history.

Exclusion criteria

Exclusion criteria: Cases of headache other than migraine. Patients who are under any other medications for migraine (e.g., long-term prophylactic anti-migraine allopathic treatment)

Design outcomes

Primary

Measure	Time frame
Reduction in MIDAS score by 10 or more points, as measured using the Migraine Disability Assessment Scale (MIDAS)Timepoint: Baseline (Day 0) & Last Followup (Day 180)	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr. Sanha

AM Shaikh Homoeopathic Medical College And Hospital Belgaum

afshanatharbalekundri@yahoo.co.in9341493285

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026